Levantinib in the Management of Differentiated Thyroid Cancer
Published: | Updated:
Therapy that targets angiogenesis has been extensively investigated in differentiated thyroid cancer (DTC) and has demonstrated significant antitumor activity.
Yujie Zhao, MD, PhD
Articles by Yujie Zhao, MD, PhD
Latest Updated Articles
Levantinib in the Management of Differentiated Thyroid CancerPublished: August 27th 2015 | Updated: April 18th 2020